# NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) HIV/AIDS RADX INNOVATION FUNNEL

> **NIH NIH N02** · MASSACHUSETTS GENERAL HOSPITAL · 2022 · $298,795

## Abstract

Commercialization Center – VentureWell
The goal of the Commercialization Center Innovation Funnel for HIV/AIDs is to provide technical, clinical, and commercialization expertise and resources to a RADx Innovation Funnel seeking to accelerate the development of point-of-care and home-based HIV diagnostic technologies. The Commercialization Center is a trans-NIH focused activity that requires professional services support across a range of commercialization domains to NIH translational activities. To support rapid technology development, consultants with specialized domain expertise are needed to assess and mitigate risks at various stages. The vetting and management of professional service consultants and vendors is a critical component of the parallelization effort to speed innovation.

## Key facts

- **NIH application ID:** 10708378
- **Project number:** 75N92022D00014-0-759202200002-1
- **Recipient organization:** MASSACHUSETTS GENERAL HOSPITAL
- **Principal Investigator:** VICTORIA HIMARAS
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $298,795
- **Award type:** —
- **Project period:** 2022-09-01 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10708378

## Citation

> US National Institutes of Health, RePORTER application 10708378, NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) HIV/AIDS RADX INNOVATION FUNNEL (75N92022D00014-0-759202200002-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10708378. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*